Feedback
ALKEM 
Reputation: 642,681 • Sep 25, 2023 6:08 PM
Alkem Laboratories shares gain on antifungal drug deal with Biosergen AB
Once the clinical trials are successfully completed in India, Biosergen and Alkem aim to expand its use for similar patient groups in the US and EU via pivotal trials.
Moneycontrol
Vote
Comment
Share
NSE:ALKEM price when posted: 3,571.45